About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The main characteristic of our group is its multidisciplinary nature, as it is comprised of neuroradiologists, technologists, and a physicist, engineer, and biochemist.
The main objectives of our projects are to gain knowledge about the pathophysiologic mechanisms implicated in several neurological diseases and to evaluate new biomarkers and therapies through the use of qualitative and quantitative magnetic resonance (MR) and computed tomography (CT) techniques, and by applying artificial intelligence tools to create prognostic models. Our focus is on the study of diseases such as multiple sclerosis, epilepsy, neuro-oncology, and stroke.
In addition, because of the experience we have acquired along the years in performing MR studies, we act as a platform for designing MR-based projects, processing images, and conducting quantitative data analysis.
The objective of this research line is to evaluate the structural changes that occur in the brain after or during epileptic seizures using different MRI techniques, as well as assess the role of MRI in the etiological diagnosis and location of the epileptogenic focus and analyze its influence on the treatment and evolution of these patients.
IP: Silvana Isabel Sarria Estrada
The objective of this research line is to evaluate the value of MRI in the diagnosis and follow-up of primary tumours of the head and neck, with special interest on the impact of radiological features in their prognosis.
IP: -
This research line aims to develop new biomarkers that capture brain function and can be implemented in the clinical routine.
IP: Deborah Pareto Onghena
This line is focused on the application of computer vision, image processing, pattern recognition, machine learning and fuzzy logic techniques to the analysis of MR images. Some areas of interest are the study of lesions, and iron quantification by means of advanced techniques such as QSM and SWI.
IP: Fco. Javier Aymerich Martínez
IP: Deborah Pareto Onghena Collaborators: Ingrid Galán Cartaña, Herena Eixarch Ahufinger, M Jesus Arevalo Navines, Giorgio Colangelo Funding agency: Instituto de Salud Carlos III Funding: 87120 Reference: PI22/01709 Duration: 01/01/2023 - 30/06/2027
IP: Jaume Sastre Garriga Collaborators: Cristina Auger Acosta, Carme Santoyo Medina, Manel Alberich Jordà, M Jesus Arevalo Navines, Lucía Gutiérrez Ruiz Funding agency: Instituto de Salud Carlos III Funding: 157300 Reference: PI22/00750 Duration: 01/01/2023 - 30/06/2027
IP: Alex Rovira Cañellas Collaborators: Dulce María Moncho Rodríguez, Sergio Cabello, Manel Alberich Jordà, Angela Vidal Jordana, Joaquin Castillo Justribo Funding agency: Instituto de Salud Carlos III Funding: 48400 Reference: PI22/01589 Duration: 01/01/2023 - 30/06/2026
IP: Carmen Tur Gomez Collaborators: Jordi Rio Izquierdo, Oscar Persiva Morenza, Elena Huerga Núñez Funding agency: Instituto de Salud Carlos III Funding: 150040 Reference: PI21/01860 Duration: 01/01/2022 - 30/06/2026
It aims to develop and validate AI algorithms that detect multiple sclerosis lesions based on magnetic resonance imaging.
The award recognizes his scientific career and his contribution to research and clinical care in multiple sclerosis.
Dr. Xavier Montalban, Dr. Álex Rovira, Dr. Mar Tintoré and Dr. Jaume Sastre Garriga have been recognised in the listing.
Magnetic Resonance image analysis
